These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2337406)

  • 1. Improved methods for the determination of 5-bromo-2-deoxyuridine labelling index in clones and colonies growing in plasma clots.
    Di Nucci GD; Tazzari PL; Bontadini A; Tassi C; Dinota A; Pileri S; Gobbi M
    Basic Appl Histochem; 1990; 34(1):71-7. PubMed ID: 2337406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium iodide.
    Trinkle LS; Swope VB; Abdel-Malek ZA; Nordlund JJ
    Cytometry; 1988 Sep; 9(5):432-5. PubMed ID: 3180943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The demonstration of proliferating cells by using monoclonal antibodies to 5-bromo-2'-deoxyuridine in the peroxidase-antiperoxidase method].
    Morenkov OS; Mantsygin IuA
    Tsitologiia; 1990; 32(12):1225-30. PubMed ID: 2103085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
    Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
    Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation.
    Gonchoroff NJ; Greipp PR; Kyle RA; Katzmann JA
    Cytometry; 1985 Nov; 6(6):506-12. PubMed ID: 3905299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy.
    Gunduz N
    Cytometry; 1985 Nov; 6(6):597-601. PubMed ID: 3933924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle kinetic measurements in an irradiated rat rhabdomyosarcoma using a monoclonal antibody to bromodeoxyuridine.
    Nüsse M; Afzal SM; Carr B; Kavanau K
    Cytometry; 1985 Nov; 6(6):611-9. PubMed ID: 4064841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofluorescent staining method for use with monoclonal antibodies.
    Costanzo C; Raza A
    Cell Biochem Funct; 1984 Jul; 2(3):153-4. PubMed ID: 6383651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved immunocytochemical procedure for high-sensitivity detection of incorporated bromodeoxyuridine.
    Beisker W; Dolbeare F; Gray JW
    Cytometry; 1987 Mar; 8(2):235-9. PubMed ID: 3582069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
    Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM
    Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 5-fluoro-2'-deoxyuridine (FdUrd) on 5-bromo-2'-deoxyuridine (BrdUrd) incorporation into DNA measured with a monoclonal BrdUrd antibody and by the BrdUrd/Hoechst quenching effect.
    Ellwart J; Dörmer P
    Cytometry; 1985 Nov; 6(6):513-20. PubMed ID: 2415309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flow cytometric analysis of cell proliferation kinetics using the anti-BrdUrd antibody].
    Sasaki K; Murakami T; Takahashi M
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2338-44. PubMed ID: 2751315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific pharmacodynamics of 5-bromo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.
    Stetson PL; Maybaum J; Wagner JG; Averill DR; Wollner IS; Knol JA; Johnson NJ; Yang ZM; Preiskorn D; Smith P
    Cancer Res; 1988 Dec; 48(23):6900-5. PubMed ID: 3180098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of S-phase cell cycle progression using 5-ethynyl-2'-deoxyuridine incorporation with click chemistry, an alternative to using 5-bromo-2'-deoxyuridine antibodies.
    Buck SB; Bradford J; Gee KR; Agnew BJ; Clarke ST; Salic A
    Biotechniques; 2008 Jun; 44(7):927-9. PubMed ID: 18533904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromodeoxyuridine incorporation into DNA of human leukemia cells is not concentration dependent.
    Powell BL; Gregory BW; Kute TE; Morgan TM; Lyerly ES; Capizzi RL
    Cytometry; 1990; 11(3):438-41. PubMed ID: 2340778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-induced cytostasis: kinetic analysis of bromodeoxyuridine-pulsed cells.
    Stevenson AP; Crissman HA; Stewart CC
    Cytometry; 1985 Nov; 6(6):578-83. PubMed ID: 4064839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.
    Begg AC; McNally NJ; Shrieve DC; Kärcher H
    Cytometry; 1985 Nov; 6(6):620-6. PubMed ID: 4064842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
    Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
    Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunocytochemical method for studying embryo cytokinetics.
    Casasco A; Calligaro A; Casasco E; Marchetti C; Poggi P; Casasco M
    Basic Appl Histochem; 1988; 32(2):293-6. PubMed ID: 3415631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-phase cell detection with a monoclonal antibody.
    Miltenburger HG; Sachse G; Schliermann M
    Dev Biol Stand; 1987; 66():91-9. PubMed ID: 3556275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.